US equities |
NVDA $204.64 ▼-4.22% INTC $65.76 ▼-28.58% MU $884.74 ▼-5.30% AMZN $240.35 ▼-1.41% AAPL $344.63 ▼-1.23% SNDK $1,150.89 ▼-13.47% AMD $504.80 ▼-10.88% MSFT $521.91 ▼-1.55%
FinancialContent

Articles published by GT Biopharma, Inc.

News headline image
GT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer
From GT Biopharma, Inc.
Via GlobeNewswire
Tickers GTBP
News headline image
GT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022
From GT Biopharma, Inc.
Via GlobeNewswire
Tickers FATE GTBP
News headline image
GT Biopharma Presents Two Posters at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
From GT Biopharma, Inc.
Via GlobeNewswire
Tickers GTBP
News headline image
GT Biopharma to Present New Data on Novel Dual-Antigen Targeting Approach Against AML at Upcoming 2022 ASH Annual Meeting
From GT Biopharma, Inc.
Via GlobeNewswire
Tickers GTBP
News headline image
GT Biopharma Reports Third Quarter Fiscal 2022 Financial Results and Business Update
From GT Biopharma, Inc.
Via GlobeNewswire
Tickers GTBP
News headline image
GT Biopharma Announces Adjournment of Special Shareholders Meeting
From GT Biopharma, Inc.
Via GlobeNewswire
Tickers GTBP